Atazanavir
In the US, Atazanavir (atazanavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.
US matches:
- Atazanavir
- Atazanavir and cobicistat
- Atazanavir Capsules
- Atazanavir Powder for Oral Suspension
- Atazanavir Sulfate
- Atazanavir
UK matches:
- Atazanavir Mylan
- ATAZANAVIR TEVA 150 MG CAPSULES HARD (Leaflet)
- ATAZANAVIR TEVA 200 MG CAPSULES HARD (Leaflet)
- ATAZANAVIR TEVA 300 MG CAPSULES HARD (Leaflet)
- ATAZANAVIR ZENTIVA 150 MG HARD CAPSULES (Leaflet)
- ATAZANAVIR ZENTIVA 200 MG HARD CAPSULES (Leaflet)
- ATAZANAVIR ZENTIVA 300 MG HARD CAPSULES (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AE08
CAS registry number (Chemical Abstracts Service)
0198904-31-3
Chemical Formula
C38-H52-N6-O7
Molecular Weight
704
Therapeutic Categories
Antiviral agent
Treatment of HIV infection
HIV protease inhibitor
Chemical Names
(3S,8S,9S,12S)-3,12-bis(1,1-dimetyletyl)-8-hydoxy-4,11-dioxo-9-(phenylmetyl)-6-((4-(2-pyridinyl)phenyl)metyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimetyl ester
(S)-{1-[N'-[(2S,3S)-2-Hydroxy-3-((S-metoxycarbonylamino-3,3-dimetylbutyrylamino)-4- phenylbutyl]-N'-(4-pyridin-2-ylbenzyl)hydrazinocarbonyl]-2,2-dimetehyletylpropyl} carbaminsäuremetylester (IUPAC)
Dimetyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate (WHO, BAN)
Foreign Names
- Atazanavirum (Latin)
- Atazanavir (German)
- Atazanavir (French)
- Atazanavir (Spanish)
Generic Names
- Atazanavir (OS: BAN)
- BMS 232632 (IS: Bristol-Myers)
- CGP 73547 (IS: Novartis)
- Latazanavir (IS)
- UNII-QZU4H47A3S (IS)
- Zrivida (IS)
- Atazanavir Sulfate (OS: USAN, BANM, JAN)
- BMS-232632-05 (IS: Bristol-Myers)
- UNII-4MT4VIE29P (IS)
Brand Names
- Anzavir-R (Atazanavir and Ritonavir)
Mylan, India - Atazor
Emcure, India - Evotaz (Atazanavir and Cobicistat)
Bristol-Myers Squibb, United States - Reyataz
Bristol Myers Squibb, Chile; Bristol-M.S., Argentina; Bristol-Myers Squibb, Mexico - Synthivan (Atazanavir and Ritonavir)
Cipla, India - Virataz
Hetero, India - Virataz-R (Atazanavir and Ritonavir)
Hetero, India - Aspen Atazanavir
Pharmacare, South Africa - Atazanavir Humax
Humax Pharmaceutical, Colombia - Atazor
Emcure, South Africa - Evotaz (Atazanavir and Cobicistat)
Bristol-Myers Squibb Pharmaceutical, United Kingdom - Reyataz
Abeefe Bristol-Myers Squibb, Peru; Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Bristol-Myers Squibb Pharmaceuticals, Austria; Haemato Pharm, Austria; Inopha, Austria
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.